Volume 81, Number 24, December 10, 2013
About this course
- Released: 12/10/2013
- Expires: 12/10/2016
An RCT to treat learning impairment in multiple sclerosis: The MEMREHAB trial
LEARNING OBJECTIVES:
Upon completion of the article by Chiaravalloti et al, the participant should be able to:
- Briefly discuss the primary mechanism underlying memory impairment in multiple sclerosis patients
- State what percentage of patients in the treatment group showed improvement in learning
- Discuss improvements in aspects of subjective everyday cognition and emotional functioning seen in the treatment group
CORE COMPETENCIES:
The article by Chiaravalloti et al covers the following core competency:
- Medical Knowledge
Prognosis of juvenile myoclonic epilepsy 45 years after onset: Seizure outcome and predictors
LEARNING OBJECTIVES:
Upon completion of the article by Senf et al, the participant should be able to:
- State the rate of 5-year terminal seizure remission on and off medications for patients with juvenile myoclonic epilepsy
- State the types of seizures most frequently seen in patients who are not seizure-free
- Discuss clinical parameters which are predictive of 5-year terminal seizure remission
CORE COMPETENCIES:
The article by Senf et al covers the following core competency:
- Medical Knowledge
AUTHOR DISCLOSURES
Refer to Information and Author section available in the Tool Bar for each article.
THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES
ACCREDITATION STATEMENT
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed. Physicians should only claim credit commensurate with the extent of their participation in the activity. The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
MISSION STATEMENT/PROGRAM OBJECTIVES
After evaluating a specific article published in Neurology, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.
PARTICIPANTS
This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.
CREDITS
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed.
The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.
DISCLOSURES
Steven Lewis, MD receives a stipend in his editorial capacity for Neurology and as an Associate Editor for Continuum: Lifelong Learning in Neurology; has received royalties for the books Field Guide to the Neurologic Examination and Neurology for the Non-Neurologist; and anticipates receiving royalties for the book Neurologic Disorders due to Systemic Disease. James WM Owens Jr. MD, PhD receives royalties from UpToDate, Waltham, MA; grant support from NIH (PI, K08NS054882); and a stipend in his editorial capacity for Neurology.
COMMERCIAL SUPPORT
This CME program receives no commercial support.
